Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-17
2006-10-17
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S375000, C435S377000, C435S006120, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
07122527
ABSTRACT:
New antisense oligonucleotide compounds inhibit expression of Akt-1 and also induce cytotoxicity in several cancer cell lines.
REFERENCES:
patent: 5958773 (1999-09-01), Monia et al.
Agrawal, Antisense Oligonucleotides: towards clinical trials 1996 Trends Biotechnol. 14: 376-387.
Brazil and Hemmings, Ten years of protein kinas B signalling: a hard Akt to follow 2001 Trends Biochem. Sci. 26: 657-664.
Crooke and Bennett, Progress in Antisense Oligonucleotide Therapeutics 1996 Annu. Rev. Pharmacol. Toxicol. 36:107-29.
Krieg, et al., CpG motifs in bacterial DNA trigger direct B-cell activation 1995 Nature 374: 546-549.
Laptev et al., Specific Inhibition of Expression of a Human Collagen Gene (COLIAI) with Modified Antisense Oligonucleotides. The Most Effective Target Sites are Clustered in Double-Stranded Regions of the Predicted Secondary Structure for the mRNA 1994 Biochemistry 33: 11033-11039.
Stocker, et al., Living with Lethal PIP3 levels: Viability of Flies Lacking PTEN Restored by a PH Domain Mutation in Akt/PKB Science, 2002, 295: 2088.
Martin, et al., Ein neuer Zugand zu 2′-0-Alkylribonucleosiden und Eigenschaften deren Oligonucleotide, Helv. Chim. Acta, 1995, 78: 486-504.
Chomczynski, P., and Sacchi, N., Single-Step Method of RNA Isolation by Acid Guanidinum Thiocyanate-Phenol-Chloroform Extraction, Anal. Biochem., 1987, 162: 156-159.
Skehan et al., New Colorimetric Cytoxicity Assay for Anticancer-Drug Screening, J. National Cancer Institute, 1990, 82: 1107-1112.
Ahn Chang Ho
Lee Young Bok
Mao Lingjun
Yoon Heejeong
Looper Valerie E.
McGarry Sean
Rexahn Corporation
LandOfFree
Use of antisense oligonucleotides to inhibit the expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of antisense oligonucleotides to inhibit the expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of antisense oligonucleotides to inhibit the expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3695613